These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 38462356

  • 1. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
    Tao SN, Liu XC, Wang YY, Yang H.
    Zhonghua Yi Xue Za Zhi; 2024 Mar 12; 104(10):758-765. PubMed ID: 38462356
    [Abstract] [Full Text] [Related]

  • 2. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J, Feng L, Tian C, Tang YL, Tang Y, Hu FQ.
    Eur Rev Med Pharmacol Sci; 2018 Dec 12; 22(23):8135-8144. PubMed ID: 30556851
    [Abstract] [Full Text] [Related]

  • 3. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J, Zhao X, Jiang H, Yang T, Li D, Yang X, Jia A, Ma Y, Qian Z.
    Tissue Cell; 2022 Aug 12; 77():101817. PubMed ID: 35679685
    [Abstract] [Full Text] [Related]

  • 4. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ, Xu WR, Chen B, Wang YY, Yang N, Wang LJ, Zhang YL.
    Eur Rev Med Pharmacol Sci; 2019 Oct 12; 23(19):8321-8331. PubMed ID: 31646562
    [Abstract] [Full Text] [Related]

  • 5. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F, Huang X, Xuan Y.
    Dis Markers; 2021 Oct 12; 2021():9950663. PubMed ID: 34512817
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
    Liu W, Zhan J, Zhong R, Li R, Sheng X, Xu M, Lu Z, Zhang S.
    Technol Cancer Res Treat; 2021 Oct 12; 20():1533033821990074. PubMed ID: 33641529
    [Abstract] [Full Text] [Related]

  • 7. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
    Wu XL, Wang LK, Yang DD, Qu M, Yang YJ, Guo F, Han L, Xue J.
    J Cell Biochem; 2018 Feb 12; 119(2):2356-2367. PubMed ID: 28884839
    [Abstract] [Full Text] [Related]

  • 8. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y, Xie L, Xu S, Yan W, Zhang H, Meng Y, Liu J, Wei X.
    Mol Cell Biochem; 2021 Nov 12; 476(11):4031-4044. PubMed ID: 34244973
    [Abstract] [Full Text] [Related]

  • 9. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y, Kuang H, Xue J, Liao L, Yin F, Zhou X.
    Biomed Pharmacother; 2017 Sep 12; 93():1230-1237. PubMed ID: 28738539
    [Abstract] [Full Text] [Related]

  • 10. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y, Peng F, Tan X, Wang J, Xu Y.
    Genes Genomics; 2021 Oct 12; 43(10):1189-1198. PubMed ID: 34417976
    [Abstract] [Full Text] [Related]

  • 11. [Kuwanon G inhibits growth, migration and invasion of gastric cancer cells by regulating the PI3K/AKT/mTOR pathway].
    Geng Z, Yang J, Niu M, Liu X, Shi J, Liu Y, Yao X, Zhang Y, Zhang X, Hu J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Aug 20; 44(8):1476-1484. PubMed ID: 39276043
    [Abstract] [Full Text] [Related]

  • 12. PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway.
    Wang S, Cheng Z, Cui Y, Xu S, Luan Q, Jing S, Du B, Li X, Li Y.
    J Transl Med; 2023 Nov 16; 21(1):819. PubMed ID: 37974250
    [Abstract] [Full Text] [Related]

  • 13. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H, Pu J, Zhou XL, Ning YY, Bai C.
    Tumour Biol; 2017 May 16; 39(5):1010428317697568. PubMed ID: 28459375
    [Abstract] [Full Text] [Related]

  • 14. Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer.
    Tang C, Wang A, Zhao Y, Mou W, Jiang J, Kuang J, Sun B, Tang E.
    Biomol Biomed; 2024 Jan 20; 24(4):968-981. PubMed ID: 38259082
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW, Wang SH, Wei X, Hou YZ, Li ZH.
    Eur Rev Med Pharmacol Sci; 2020 Dec 20; 24(24):12655-12666. PubMed ID: 33378012
    [Abstract] [Full Text] [Related]

  • 16. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
    Ma X, Ren H, Zhang Y, Wang B, Ma H.
    Environ Toxicol; 2022 Dec 20; 37(12):3013-3027. PubMed ID: 36125241
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T, Chen H, Wang P, Yang N, Bao J.
    Cancer Biother Radiopharm; 2020 Nov 20; 35(9):661-672. PubMed ID: 32275162
    [Abstract] [Full Text] [Related]

  • 18. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, Hu Y, Song W, Zhou J.
    J Exp Clin Cancer Res; 2018 Dec 05; 37(1):304. PubMed ID: 30518405
    [Abstract] [Full Text] [Related]

  • 19. ESM1 promotes angiogenesis in colorectal cancer by activating PI3K/Akt/mTOR pathway, thus accelerating tumor progression.
    Yang L, Dong Z, Li S, Chen T.
    Aging (Albany NY); 2023 Mar 07; 15(8):2920-2936. PubMed ID: 37100467
    [Abstract] [Full Text] [Related]

  • 20. P300 increases CSNK2A1 expression which accelerates colorectal cancer progression through activation of the PI3K-AKT-mTOR axis.
    Liu J.
    Exp Cell Res; 2023 Sep 01; 430(1):113694. PubMed ID: 37391010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.